SEC Form D · filed March 6, 2020
Adamis Pharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Karen K. Daniels · SAN DIEGO, CAExecRoshawn C. Blunt · SAN DIEGO, CADirectorRobert O. Hopkins · SAN DIEGO, CAExecHoward C. Birndorf · San Diego, CADirectorRichard C. Williams · San Diego, CADirectorRonald B. Moss · San Diego, CAExecDennis J. Carlo · SAN DIEGO, CAExec · DirectorDavid J. Marguglio · San Diego, CAExec · DirectorLynn Yang · San Diego, CADirectorCharles B. Chippero · ROSWELL, GADirectorYi Liu · San Diego, CADirectorMichael B. Dickens · PITTSBURGH, PAExec · DirectorCarl Gordon · San Diego, CAExec · DirectorDavid Choi · Laurel, MDExecAlan B. Laing · PHOENIX, AZExecIsaiah Gresham · Tacoma, WAExecDerek P. Hodges · Huntingtown, MDDirectorZamyra E. Cammans · Luxembourg, LuxembourgExecJosh E. Glaser · New York, NYExecAdam E. Graev · New York, NYExecAlan E. Turner · George Town, Grand Cayman, Cayman IslandsExec · DirectorJoseph P. Simpson · Owings, MDDirectorBlake P. Conner · Miami, FLDirectorHam K. Serunjogi · San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗